Biocon inks licensing, supply pact with South Korea’s Handok for chronic weight management product, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

​Biocon Ltd on Friday said it has signed an exclusive licensing and supply agreement with South Korea’s Handok for commercialisation of its complex drug product, synthetic Liraglutide, used in the treatment of chronic weight managemen, ​Biocon Ltd on Friday said it has signed an exclusive licensing and supply agreement with South Korea’s Handok for commercialisation of its complex drug product, synthetic Liraglutide, used in the treatment of chronic weight managemen, , Read More